BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 16445858)

  • 1. Identification of mitogen-activated protein kinase docking sites in enzymes that metabolize phosphatidylinositols and inositol phosphates.
    Caldwell KK; Sosa M; Buckley CT
    Cell Commun Signal; 2006 Jan; 4():2. PubMed ID: 16445858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fear conditioning is associated with altered integration of PLC and ERK signaling in the hippocampus.
    Buckley CT; Caldwell KK
    Pharmacol Biochem Behav; 2004 Dec; 79(4):633-40. PubMed ID: 15582671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docking sites on mitogen-activated protein kinase (MAPK) kinases, MAPK phosphatases and the Elk-1 transcription factor compete for MAPK binding and are crucial for enzymic activity.
    Bardwell AJ; Abdollahi M; Bardwell L
    Biochem J; 2003 Mar; 370(Pt 3):1077-85. PubMed ID: 12529172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitogen-activated protein kinase (MAPK)-docking sites in MAPK kinases function as tethers that are crucial for MAPK regulation in vivo.
    Grewal S; Molina DM; Bardwell L
    Cell Signal; 2006 Jan; 18(1):123-34. PubMed ID: 15979847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spatially separate docking sites on ERK2 regulate distinct signaling events in vivo.
    Dimitri CA; Dowdle W; MacKeigan JP; Blenis J; Murphy LO
    Curr Biol; 2005 Jul; 15(14):1319-24. PubMed ID: 16051177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of adenosine triphosphate on phosphate uptake in renal proximal tubule cells: involvement of PKC and p38 MAPK.
    Lee YJ; Park SH; Jeung TO; Kim KW; Lee JH; Han HJ
    J Cell Physiol; 2005 Oct; 205(1):68-76. PubMed ID: 15880445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor receptor signaling activates the human interstitial collagenase promoter via the bipartite Ets-AP1 element.
    Newberry EP; Willis D; Latifi T; Boudreaux JM; Towler DA
    Mol Endocrinol; 1997 Jul; 11(8):1129-44. PubMed ID: 9212060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The signalling profile of recombinant human orexin-2 receptor.
    Tang J; Chen J; Ramanjaneya M; Punn A; Conner AC; Randeva HS
    Cell Signal; 2008 Sep; 20(9):1651-61. PubMed ID: 18599270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of key residues in the A-Raf kinase important for phosphoinositide lipid binding specificity.
    Johnson LM; James KM; Chamberlain MD; Anderson DH
    Biochemistry; 2005 Mar; 44(9):3432-40. PubMed ID: 15736953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered signal transduction secondary to surface IgM cross-linking on B-chronic lymphocytic leukemia cells. Differential activation of the phosphatidylinositol-specific phospholipase C.
    Hivroz C; Gény B; Brouet JC; Grillot-Courvalin C
    J Immunol; 1990 Mar; 144(6):2351-8. PubMed ID: 2107258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signalling specificity of Ser/Thr protein kinases through docking-site-mediated interactions.
    Biondi RM; Nebreda AR
    Biochem J; 2003 May; 372(Pt 1):1-13. PubMed ID: 12600273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of PLC-gamma1 activity converts nerve growth factor from an anti-mitogenic to a mitogenic signal in CHO cells.
    Zapf-Colby A; Eichhorn J; Webster NJ; Olefsky JM
    Oncogene; 1999 Sep; 18(35):4908-19. PubMed ID: 10490825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gi-mediated activation of mitogen-activated protein kinase (MAPK) pathway by receptor mimetic basic secretagogues of connective tissue-type mast cells: bifurcation of arachidonic acid-induced release upstream of MAPK.
    Shefler I; Seger R; Sagi-Eisenberg R
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1654-61. PubMed ID: 10336565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical and molecular analysis of the interaction between ERK2 MAP kinase and hypoxia inducible factor-1α.
    Karapetsas A; Giannakakis A; Pavlaki M; Panayiotidis M; Sandaltzopoulos R; Galanis A
    Int J Biochem Cell Biol; 2011 Nov; 43(11):1582-90. PubMed ID: 21807114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new link between the c-Abl tyrosine kinase and phosphoinositide signalling through PLC-gamma1.
    Plattner R; Irvin BJ; Guo S; Blackburn K; Kazlauskas A; Abraham RT; York JD; Pendergast AM
    Nat Cell Biol; 2003 Apr; 5(4):309-19. PubMed ID: 12652307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of phosphoinositide-specific phospholipase C.
    Rhee SG
    Annu Rev Biochem; 2001; 70():281-312. PubMed ID: 11395409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SHIP2 multiple functions: a balance between a negative control of PtdIns(3,4,5)P₃ level, a positive control of PtdIns(3,4)P₂ production, and intrinsic docking properties.
    Erneux C; Edimo WE; Deneubourg L; Pirson I
    J Cell Biochem; 2011 Sep; 112(9):2203-9. PubMed ID: 21503961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The docking protein Gab1 is an essential component of an indirect mechanism for fibroblast growth factor stimulation of the phosphatidylinositol 3-kinase/Akt antiapoptotic pathway.
    Lamothe B; Yamada M; Schaeper U; Birchmeier W; Lax I; Schlessinger J
    Mol Cell Biol; 2004 Jul; 24(13):5657-66. PubMed ID: 15199124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of pertussis toxin on extracellular signal-regulated kinase activation in hepatocytes by hormones and receptor-independent agents: evidence suggesting a stimulatory role of G(i) proteins at a level distal to receptor coupling.
    Melien O; Sandnes D; Johansen EJ; Christoffersen T
    J Cell Physiol; 2000 Jul; 184(1):27-36. PubMed ID: 10825231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation by cAMP-dependent protein kinease of a G-protein-mediated phospholipase C.
    Liu M; Simon MI
    Nature; 1996 Jul; 382(6586):83-7. PubMed ID: 8657310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.